5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 0.63▲ | 0.63▲ | 0.63▲ | 0.64▲ | 0.65▲ |
MA10 | 0.63▲ | 0.63▲ | 0.63▲ | 0.65▼ | 0.70▼ |
MA20 | 0.62▲ | 0.62▲ | 0.63▲ | 0.65▼ | 0.84▼ |
MA50 | 0.64▼ | 0.64▼ | 0.65▼ | 0.73▼ | 1.69▼ |
MA100 | 0.65▼ | 0.66▼ | 0.65▼ | 0.86▼ | N/A |
MA200 | 0.66▼ | 0.65▼ | 0.68▼ | 1.52▼ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.003▲ | 0.004▲ | 0.003▲ | 0.004▲ | 0.086▲ |
RSI | 53.898▲ | 52.135▲ | 50.287▲ | 45.107▼ | 37.007▼ |
STOCH | 57.144 | 83.734▲ | 85.845▲ | 38.483 | 12.308▼ |
WILL %R | -7.718▲ | -7.718▲ | -7.718▲ | -54.605 | -89.985▼ |
CCI | 66.294 | 75.611 | 78.645 | -75.706 | -75.765 |
Friday, August 01, 2025 02:36 AM
FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 275+ patents issued and pending with a focus on the development ...
|
Thursday, July 31, 2025 01:41 PM
FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 275+ patents issued and pending with a focus on the development of therapeutics and potential cures ...
|
Monday, July 28, 2025 05:42 AM
FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 275+ patents issued and pending with a focus on the development of therapeutics and potential cures ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
01/08/25 | 0.637 | 0.658 | 0.603 | 0.649 | 746,800 |
31/07/25 | 0.63 | 0.648 | 0.619 | 0.637 | 179,600 |
30/07/25 | 0.60 | 0.657 | 0.58 | 0.635 | 580,200 |
29/07/25 | 0.64 | 0.65 | 0.60 | 0.607 | 947,900 |
28/07/25 | 0.679 | 0.7197 | 0.6388 | 0.656 | 850,589 |
25/07/25 | 0.67 | 0.70 | 0.645 | 0.677 | 472,600 |
24/07/25 | 0.67 | 0.67 | 0.64 | 0.657 | 302,100 |
23/07/25 | 0.67 | 0.67 | 0.606 | 0.662 | 501,700 |
22/07/25 | 0.676 | 0.69 | 0.645 | 0.67 | 459,800 |
21/07/25 | 0.69 | 0.69 | 0.661 | 0.667 | 293,900 |
|
|
||||
|
|
||||
|
|